Tigecycline activity: low resistance rates but problematic disc breakpoints revealed by a multicentre sentinel survey in the UK.

@article{Hope2010TigecyclineAL,
  title={Tigecycline activity: low resistance rates but problematic disc breakpoints revealed by a multicentre sentinel survey in the UK.},
  author={Russell Hope and Shazad Mushtaq and Dorothy James and Teresa Pllana and Marina Warner and David M Livermore},
  journal={The Journal of antimicrobial chemotherapy},
  year={2010},
  volume={65 12},
  pages={
          2602-9
        }
}
OBJECTIVES A multicentre surveillance of tigecycline activity against relevant pathogens in the UK. METHODS Forty-three representative UK hospitals were each asked to test 150 consecutive, clinically significant isolates from hospitalized patients, excluding those from urine or faeces. The sentinel laboratories tested all these isolates against a panel of antibiotics by the BSAC disc method and a selection of isolates were retested centrally by the BSAC agar dilution method. RESULTS The… 

Tables from this paper

Comparative activity of tigecycline and tetracycline on Gram-negative and Gram-positive bacteria revealed by a multicentre study in four North European countries

Tigecycline showed good overall in vitro activity against Gram-positive and Gram-negative isolates, including both tetracycline-susceptible and resistant isolates.

Tigecycline Resistance among Clinical Isolates of Staphylococcus aureus from North-east India

Resistance to cycline group of antibiotics with special reference to Tigecycline is not frequently reported from India, which is of clinical interest in terms of selection of proper antimicrobial chemotherapy and also using TigecYcline for phenotypic screening of cyclineGroup of antibiotic resistance in Staphylococcus aureus.

Comparative Evaluation of Tigecycline Susceptibility Testing Methods for Expanded-Spectrum Cephalosporin- and Carbapenem-Resistant Gram-Negative Pathogens

Evaluated methods of tigecycline susceptibility testing with 241 expanded-spectrum cephalosporin-resistant and/or carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii clinical isolates found them to require confirmation by BMD or Etest for multidrug-resistant pathogens.

Mechanisms of tigecycline resistance in the Enterobacteriaceae and Acinetobacter baumannii

The hypothesis that tigecycline resistance in clinical isolates of Gram-negative bacteria arises as a result of the up-regulated activity of intrinsic efflux systems of the RND family is supported.

Antimicrobial Susceptibility Testing for Enterococci

unique problems and gaps with the performance and clinical utility of antimicrobial susceptibility testing for enterococci, provide recommendations for clinical laboratories to circumvent select problems, and address potential future innovations that can bridge major gaps in susceptibility testing.

False non-susceptible results of tigecycline susceptibility testing against Enterobacteriaceae by an automated system: a multicentre study.

This study aimed to systematically determine the error rates of tigecycline AST for Enterobacteriaceae by Vitek 2 as well as other automated systems in comparison to a reference method.

Colistin and tigecycline resistance in carbapenemase‐producing Gram‐negative bacteria: emerging resistance mechanisms and detection methods

Common detection methods are mainly antibiotic sensitivity testing with broth microdilution while molecular identification tools are mostly PCR and WGS.

Antimicrobials New and Old Molecules in the Fight Against Multi-Resistant Bacteria

MRSA, in par-ticular, is the most relevant Gram-positive multi-resistant pathogen in terms of diffusion and overall clinical impact, being a leading cause for healthcare-asso-ciated infections worldwide, as well as an emerging cause of community-acquired infections that are often associated with novel MRSA strains.

References

SHOWING 1-10 OF 22 REFERENCES

Determination of disc breakpoints and evaluation of Etests for tigecycline susceptibility testing by the BSAC method.

Disc breakpoints corresponding to BSAC MIC breakpoints were defined for 15 microg tigecycline discs and have been adopted by the BSAC.

BSAC standardized disc susceptibility testing method (version 7).

  • J. Andrews
  • Medicine, Biology
    The Journal of antimicrobial chemotherapy
  • 2008
The changes that have been made to the previous version of the recommendations (version 6) are as follows: medium and incubation condition for testing Acinetobacter spp. (Tables 1 and 6); use of

Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests.

This paper attempts to summarize the philosophy of the British Society for Antimicrobial Chemotherapy (BSAC) Working Party in its approach to setting breakpoints and to update the activities of the Working Party since it initially published breakpoints, approximately 10 years ago.

BSAC standardized disc susceptibility testing method (version 6).

  • J. Andrews
  • Medicine
    The Journal of antimicrobial chemotherapy
  • 2007
EUCAST is a project to harmonize antimicrobial breakpoints, including previously established values that varied among countries, and is being undertaken by the European Committee on Antimicrobial Susceptibility Testing with the support and collaboration of the national committees.

Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis

Reports from laboratories provide valuable information on trends and antibiotic resistance in bacteraemia and show a worrying increase in resistance to important antibiotics.

Determination of minimum inhibitory concentrations.

  • J. Andrews
  • Medicine, Biology
    The Journal of antimicrobial chemotherapy
  • 2001
Standardized methods for determining minimum inhibitory concentrations and MBCs are described and like all standardized procedures, the method must be adhered to and may not be adapted by the user.